This issue of Hematology/Oncology Clinics is focused on Prostate Cancer and highlights topics such as: Prevention, Early Detection, Biomarkers, Risk stratification, Imaging in Prostate Cancer, Adjuvant hormonal therapy, Management of patient with biochemical relapse, Management of patient with newly metastatic disease, and Bone Health Management.
HEMATOLOGY/ONCOLOGY. CLINICS. OF. NORTH. AMERICA. FORTHCOMING ISSUES RECENT ISSUES April 2020 Myelodysplastic Syndromes ... Editor October 2019 Transfusion Medicine Eric A. Gehrie and Edward L. Snyder, Editors August 2019 Non-Hodgkin's ...
Jonathan E. Mcconathy, Samuel J. Galgano. Fig. 2. Initial staging of a 58-year-old man with a pancreatic head mass. FDG-PET/contrast-enhanced CT scan shows 2 small foci of hypermetabolic activity (red arrows) suspicious for malignancy ...
However, it had poor sensitivity in detecting nodal disease, and interobserver agreement for both local and nodal staging was suboptimal.22 Similar to prostate imaging-reporting and data system (PIRADS) for prostate cancer, ...
This issue of Hematology/Oncology Clinics, guest edited by Dr. Glenn J. Hanna, will focus on Head and Neck Cancer. This issue is one of six selected each year by our series consulting editors, Dr. George P. Canellos and Dr. Edward J. Benz.
The Guest Editors of this issue of Urologic Clinics of North America have put together a comprehensive collection of articles that provides the current knowledge on urologic cancer immunotherapy.
BRCA1 and BRCA2 mutations increase the risk of breast and ovarian cancer, fallopian tube cancer, male breast cancer, and prostate cancer. Furthermore, BRCA2 mutations are associated with PDAC and melanoma risk, whereas those ...
Finally, it is recommended that men with Lynch syndrome consider beginning shared decisionmaking about prostate cancer screening with their physician at age 40 and consider screening at annual intervals rather than every other year.
metastasis has been made due to costs associated with treatment and hospitalization.4 Advances in early cancer detection and improvements in therapeutic care to patients with systemic cancers are expected to result in reduced metastases ...
Topics include: Targeting IGF-1R, Tyrosine Kinase Inhibitors in Lung Cancer, Targeting mTOR, Targeting Hedgehog, Mitotic Inhibitors, Topoisomerase I Inhibitors , and New Strategies and Drugs Inhibiting Folate Pathways.
The Guest Editor updates readers on recent and ongoing trials in chemoprevention of this disease and reviews recent updates in management including surgery (e.g. robotics, laparoscopy), radiation oncology (e.g.